Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Equity (Tables)

v3.7.0.1
Shareholders' Equity (Tables)
6 Months Ended
Jun. 30, 2017
Shareholders' Equity [Abstract]  
Schedule of key assumptions used model at inception
    Inception   1/30/2017
         
Stock Price   $0.00 - $60.00   $0.00 - $6.20
Exercise Price   $22.40   $22.40
Term   .5 years   0.72 to 0.83 years
Risk Free Interest Rate   .39% - .47%   0.81%
Volatility   60%   60%
Dividend Rate   0%   0%
Schedule of shortfall provision derivative liability
Balance – December 31, 2016   $ 2,093,623  
Fair Value Adjustment     844,112  
Extinguishment of Liability     (2,937,735 )
Balance – June 30, 2017   $ -
Schedule of outstanding stock warrants

    Number of Shares     Average Exercise Price     If exercised   Expiration Date
Outstanding - December 31, 2016     148,777     $ 3.02          
Granted – January 30, 2017     3,112,871       5.16         January 31, 2022
Granted – June 30, 2017     575,000       1.90          
Granted – June 30, 2017     100,000       2.19          
Exercised     148,777                  
Outstanding, March 31, 2017     3,787,871     $ 4.59          
Warrants exercisable at March 31, 2017     3,787,871                  
Schedule of the company's stock options
    Number of Shares Underlying Options     Weighted Average Exercise Price     Weighted
Average
Grant Date
Fair Value
    Weighted Average
Remaining
Contractual
Life
    Aggregate Intrinsic 
Value (1)
 
                               
Outstanding at December 31, 2016     12,250     $ 19.35     $ 4.78       4.84                -  
                                         
For the six months ended June 30, 2017                                        
Granted     -       -       -       -          
Exercised     -       -       -       -          
Expired     -       -       -       -          
                                         
Outstanding at June 30, 2017     12,250     $ 19.35     $ 4.78       4.35       -  
                                         
Outstanding and Exercisable at June 30, 2017     2,722     $ 19.35     $ 4.78       4.35       -  

 

(1) The aggregate intrinsic value is based on the $1.65 closing price as of June 30, 2017 for the Company’s Common Stock.
Schedule of following information applies to options outstanding
Options Outstanding   Options Exercisable  
Exercise Price   Number of Shares Underlying Options     Weighted Average Remaining Contractual Life     Number Exercisable     Exercise Price  
$12.00     1,000       4.35       222     $ 12.00  
$20.00     11,250       4.35       2,500     $ 20.00  
      12,250       4.35       2,722